Luxembourg-based life sciences company Eurofins Scientific plans to acquire DiscoverX, a reagents provider based in the US.
The acquisition will strengthen Eurofins Scientific’s drug discovery services.
"Baxter International has announced the acquisition of Claris Injectables for approximately $625m."
Baxter International has announced the acquisition of Claris Injectables for approximately $625m.
Baxter is a medical products company based in the US, while Claris is an injectables pharmaceutical company based in India.
The acquisition will provide Baxter with access to Claris’ product portfolio and pipeline and strengthen its position in the generic injectable medicines market.